improving second-line treatments in dlbcl
Published 2 years ago • 109 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
1:13
second-line treatment strategies for patients with relapsed dlbcl
-
4:01
first- and second-line treatment in dlbcl
-
1:34
advances and unmet needs in second-line treatment of dlbcl
-
3:52
updates on the use of car-t therapy for the treatment of dlbcl in the second-line setting
-
1:15
the patient pathway to survival in second line dlbcl: improving access to car-t
-
1:45
improving the frontline treatment of dlbcl
-
1:31
the current state of treatment for limited-stage dlbcl
-
10:07
understanding diffuse large b-cell lymphoma with bruce cheson, md, facp, faaas, fasco
-
29:38
dlbcl treatment approaches: what you need to know
-
10:09
understanding diffuse large b-cell lymphoma with jennifer amengual, md
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
1:56
the need for new treatment strategies for patients with dlbcl
-
2:45
the value of axi-cel as a second-line treatment in r/r lbcl
-
2:37
potential second-line treatment for indolent lymphoma
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
3:01
how the treatment of dlbcl and fl are changing in the uk
-
1:17
changes in second-line lymphoma treatment
-
1:26
can we improve on r-chop for the frontline treatment of dlbcl?
-
2:19
primary analysis of the transform study: liso-cel vs soc as second-line treatment for r/r lbcl
-
2:31
brentuximab for second-line lymphoma treatment
-
3:04
applying molecular understanding of dlbcl to management strategies
-
0:46
advancements in the dlbcl treatment landscape